Related references
Note: Only part of the references are listed.Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): The NORDIC NEC study
H. Sorbye et al.
ANNALS OF ONCOLOGY (2013)
Are G3 ENETS neuroendocrine neoplasms heterogeneous?
Fritz-Line Velayoudom-Cephise et al.
ENDOCRINE-RELATED CANCER (2013)
Incidence and survival of neuroendocrine tumours in the Netherlands according to histological grade: Experience of two decades of cancer registry
Catharina M. Korse et al.
EUROPEAN JOURNAL OF CANCER (2013)
Are Neuroendocrine Tumors Going Mainstream?
Matthew H. Kulke
JOURNAL OF CLINICAL ONCOLOGY (2013)
Feasibility and efficacy of combined cisplatin plus irinotecan chemotherapy for gastroenteropancreatic neuroendocrine carcinomas
Z. H. Lu et al.
MEDICAL ONCOLOGY (2013)
Antitumor Effect of Everolimus in Preclinical Models of High-Grade Gastroenteropancreatic Neuroendocrine Carcinomas
Julien Bollard et al.
NEUROENDOCRINOLOGY (2013)
Consensus Guidelines for the Management and Treatment of Neuroendocrine Tumors
Pamela L. Kunz et al.
PANCREAS (2013)
Colorectal Poorly Differentiated Neuroendocrine Carcinomas and Mixed Adenoneuroendocrine Carcinomas: Insights Into the Diagnostic Immunophenotype, Assessment of Methylation Profile, and Search for Prognostic Markers
Stefano La Rosa et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
Small Cell and Large Cell Neuroendocrine Carcinomas of the Pancreas are Genetically Similar and Distinct From Well-differentiated Pancreatic Neuroendocrine Tumors
Shinichi Yachida et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
FOLFIRI regimen: an effective second-line chemotherapy after failure of etoposide-platinum combination in patients with neuroendocrine carcinomas grade 3
O. Hentic et al.
ENDOCRINE-RELATED CANCER (2012)
Choice of tumour markers in patients with neuroendocrine tumours is dependent on the histological grade. A marker study of Chromogranin A, Neuron specific enolase, Progastrin-releasing peptide and cytokeratin fragments
Catharina M. Korse et al.
EUROPEAN JOURNAL OF CANCER (2012)
Colorectal neuroendocrine carcinomas and adenocarcinomas share oncogenic pathways. A clinico-pathologic study of 12 cases
Raymond Karkouche et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2012)
Comparison of Chemotherapeutic Treatment Outcomes of Advanced Extrapulmonary Neuroendocrine Carcinomas and Advanced Small-Cell Lung Carcinoma
T. Terashima et al.
NEUROENDOCRINOLOGY (2012)
Lessons on Tumour Response: Imaging during Therapy with 177Lu-DOTA-octreotate. A Case Report on a Patient with a Large Volume of Poorly Differentiated Neuroendocrine Carcinoma
Ulrike Garske et al.
THERANOSTICS (2012)
Current Trends of the Incidence and Pathological Diagnosis of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) in Korea 2000-2009: Multicenter Study
Mee-Yon Cho et al.
CANCER RESEARCH AND TREATMENT (2012)
Clinical Effect of Temozolomide-Based Chemotherapy in Poorly Differentiated Endocrine Carcinoma After Progression on First-Line Chemotherapy
Staffan Welin et al.
CANCER (2011)
Impact of the Ki-67 proliferation index on response to peptide receptor radionuclide therapy
Samer Ezziddin et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2011)
Prognostic Validity of a Novel American Joint Committee on Cancer Staging Classification for Pancreatic Neuroendocrine Tumors
Jonathan R. Strosberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Metastatic and Locally Advanced Pancreatic Endocrine Carcinomas: Analysis of Factors Associated With Disease Progression
Francesco Panzuto et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
High-grade neuroendocrine carcinoma of the colon, long-term survival in advanced disease
Derek G. Power et al.
MEDICAL ONCOLOGY (2011)
Progression and survival results after radical hepatic metastasectomy of indolent advanced neuroendocrine neoplasms (NENs) supports an aggressive surgical approach
Akshat Saxena et al.
SURGERY (2011)
Mammalian target of rapamycin expression in poorly differentiated endocrine carcinoma: clinical and therapeutic future challenges
Laura Catena et al.
TARGETED ONCOLOGY (2011)
Nordic Guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours
Eva Tiensuu Janson et al.
ACTA ONCOLOGICA (2010)
Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE)
R. Garcia-Carbonero et al.
ANNALS OF ONCOLOGY (2010)
Should Extrapulmonary Small Cell Cancer Be Managed Like Small Cell Lung Cancer?
Sinead M. Brennan et al.
CANCER (2010)
Expression of an activated mammalian target of rapamycin (mTOR) in gastroenteropancreatic neuroendocrine tumors
Takashi Shida et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
18F-Fluorodeoxyglucose Positron Emission Tomography Predicts Survival of Patients with Neuroendocrine Tumors
Tina Binderup et al.
CLINICAL CANCER RESEARCH (2010)
Functional Imaging of Neuroendocrine Tumors: A Head-to-Head Comparison of Somatostatin Receptor Scintigraphy, 123I-MIBG Scintigraphy, and 18F-FDG PET
Tina Binderup et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
The NANETS Consensus Guidelines for the Diagnosis and Management of Poorly Differentiated (High-Grade) Extrapulmonary Neuroendocrine Carcinomas
Jonathan R. Strosberg et al.
PANCREAS (2010)
The epidemiology and survival of extrapulmonary small cell carcinoma in South East England, 1970-2004
Yien Ning S. Wong et al.
BMC CANCER (2009)
Clinical and therapeutic aspects of extrapulmonary small cell carcinoma
Annemiek M. E. Walenkamp et al.
CANCER TREATMENT REVIEWS (2009)
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Chemotherapy in Patients with Neuroendocrine Tumors
Barbro Eriksson et al.
NEUROENDOCRINOLOGY (2009)
Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity?
Jinru Shia et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
Retrospective study of clinicopathologic features and prognosis of high-grade neuroendocrine carcinoma of the esophagus
Dipen M. Maru et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
Histologic grade is correlated with outcome after resection of hepatic neuroendocrine neoplasms
Clifford S. Cho et al.
CANCER (2008)
One hundred years after Carcinoid: Epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States
James C. Yao et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Small-cell carcinoma of the esophagus and gastroesophageal junction: review of the Memorial Sloan-Kettering experience
G. Y. Ku et al.
ANNALS OF ONCOLOGY (2008)
Curative surgery after neoadjuvant chemotherapy in metastatic poorly differentiated neuroendocrine carcinoma
H. Sorbye et al.
EJSO (2007)
Extrapulmonary small-cell carcinoma compared with small-cell lung carcinoma - A retrospective single-center study
Irfan Cicin et al.
CANCER (2007)
Pulmonary and extrapulmonary poorly differentiated large cell neuroendocrine carcinomas - Diagnostic and prognostic features
Antongiulio Faggiano et al.
CANCER (2007)
Small cell carcinomas of the gastrointestinal tract: Clinicopathological features and treatment approach
Baruch Brenner et al.
SEMINARS IN ONCOLOGY (2007)
Rare tumors of the colon and rectum: a national review
Hakjung Kang et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2007)
Extrapulmonary small cell carcinoma: Single center experience with 61 patients
Sung Sook Lee et al.
ACTA ONCOLOGICA (2007)
Phase II trial of paclitaxel, carboplatin, and etoposide in advanced poorly differentiated neuroendocrine carcinoma: A Minnie Pearl Cancer Research Network Study
John D. Hainsworth et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Successful chemotherapy and 90Y-DOTATOC in a patient with mediastinal highly aggressive neuroendocrine carcinoma
Nicola Fazio et al.
ACTA ONCOLOGICA (2006)
Neuroendocrine carcinomas of the colon and rectum
PE Bernick et al.
DISEASES OF THE COLON & RECTUM (2004)
Small-cell carcinomas of the gastrointestinal tract: A review
B Brenner et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Genetic alterations in poorly differentiated endocrine carcinomas of the gastrointestinal tract
S Pizzi et al.
CANCER (2003)
Genetic evidence for the multi-step progression of mixed glandular-neuroendocrine gastric carcinomas
KM Kim et al.
VIRCHOWS ARCHIV (2002)
Genetic alterations in poorly differentiated endocrine colon carcinomas developing in tubulo-villous adenomas: a report of two cases
A Ubiali et al.
VIRCHOWS ARCHIV (2001)
Share Paper
